Beschreibung:
<jats:p>Herein, a series of novel 1<jats:italic>H</jats:italic>-1,2,3-triazole and carboxylate derivatives of metronidazole (<jats:bold>5a–i</jats:bold> and <jats:bold>7a–e</jats:bold>) were synthesized and evaluated for their antimicrobial activity in vitro. All the newly synthesized compounds were characterized by <jats:sup>1</jats:sup>H NMR, <jats:sup>13</jats:sup>C NMR, HRMS, and <jats:sup>19</jats:sup>F NMR (<jats:bold>5b</jats:bold>, <jats:bold>5c</jats:bold> and <jats:bold>5h</jats:bold>) spectroscopy wherever applicable. The structures of compounds <jats:bold>3</jats:bold>, <jats:bold>5c</jats:bold> and <jats:bold>7b</jats:bold> were unambiguously confirmed by single crystal X-ray analysis diffraction method. Single crystal X-ray structure analysis supported the formation of the metronidazole derivatives. The antimicrobial (antifungal and antibacterial) activity of the prepared compounds was studied. All compounds (except <jats:bold>2</jats:bold> and <jats:bold>3</jats:bold>) showed a potent inhibition rate of fungal growth as compared to control and metronidazole. The synthetic compounds also showed higher bacterial growth inhibiting effects compared to the activity of the parent compound. Amongst the tested compounds <jats:bold>5b</jats:bold>, <jats:bold>5c</jats:bold>, <jats:bold>5e</jats:bold>, <jats:bold>7b</jats:bold> and <jats:bold>7e</jats:bold> displayed excellent potent antimicrobial activity. The current study has demonstrated the usefulness of the 1<jats:italic>H</jats:italic>-1,2,3-triazole moiety in the metronidazole skeleton.</jats:p>